Advanced and experienced hematology and cancer care.
Oncology Specialists of Charlotte Welcomes Dr. Nasfat J. Shehadeh to the practice!
Learn More
Non-small Cell Lung Cancer

Phase 3 study comparing niraparib plus pembrolizumab versus placebo plus pembrolizumab as maintenance therapy for patients that have remained stable or responded to first line platinum based chemo plus pembrolizumab for stage IIIB or IV non-small cell lung cancer (NSCLC).

By Adam Lingle | Posted in Clinical Trials | Leave a comment

Subscribe to our Newsletter!

Signup today for free and be the first to get notified on new updates.